Responsibilities:

• Performs interpretation of molecular results to include next generation sequencing as well as electronic release of reviewed cases,
• Reads and interprets laboratory data.
• Performs quality control and assurance procedures and participates in departmental professional quality control and quality assurance activities.
• Participates in several functions involved in day-to-day operations, including molecular case sign out responsibilities with full time availability to interact with our clients for Pre-Analytical, Analytical, and Post-Analytical questions.
• Builds effective relationships with referring physicians and ensures excellent client follow-up.
• Provides input in the decision- making process regarding utilization of state-of-the-art technologies, as well as innovative diagnostic or therapeutic testing in Hematopathology and Solid Tumors.
• Participate in presentations at national scientific meetings, and in preparing publications for submission to peer-reviewed journals.

Requirements:

• M.D. or D.O. degree required and M.D/Ph.D., or Ph.D. preferred; Board certification or board eligibility in Molecular Genetics Pathology through the American Board of Pathology and Medical Genetics or Clinical Molecular Genetics through the American Board of Medical Genetics.
• At least five years of attending level experience.
• At least two years’ experience signing out Molecular Oncology cases working with NGS.
• Board certification in Molecular Genetics Pathology through the American Board of Pathology OR Medical Genetics or Clinical Molecular Genetics through the American Board of Medical Genetics.
• Travel: less than 10%